Physician profile
Anthereca Lane
NPI 1073722179
$941.38
in general payments reported to CMS, 2019-2025
9 companies · $195 in 2025
The $195 reported for 2025 was more than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $117 · 2021: $26.68 · 2022: $193 · 2023: $217 · 2024: $193 · 2025: $195.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $605.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $605.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Gynesonics, INC. | $544.09 | 2022-2024 | Sonata Sonography-Guided Transcervical Fibroid Ablation System |
| Abbvie INC. | $164.15 | 2020-2025 | |
| Dexcom, INC. | $59.96 | 2025 | Dexcom G6 Transmitter |
| Sage Therapeutics, LLC | $50.81 | 2025 | Zurzuvae |
| Shield Therapeutics INC | $41.39 | 2024-2025 | |
| Exeltis, USA INC. | $23.40 | 2025 | Slynd |
| Pfizer INC. | $21.99 | 2025 | |
| Mayne Pharma Commercial LLC | $19.38 | 2024 | |
| Abbott Laboratories | $16.21 | 2023 | Freestyle Libre 3 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Anthereca Lane listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.